Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Glenmark Pharmaceuticals Limited

November 2025

  • Home
  • Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals... Market Share Analysis for November 2025

Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India.
Year Founded1977
Employees> 10001
Annual Revenue> $1B
glenmarkpharma-us.com
glenmarkpharma.com.br
glenmarkpharma.com
Glenmark Pharmaceuticals Limited
Showing Glenmark Pharmaceuticals Limited's traffic and engagement information for its main website (including company regionals)
  • glenmarkpharma.com
    glenmarkpharma.com
  • glenmarkpharma-us.com
    glenmarkpharma-us.com
  • glenmarkpharma.com.br
    glenmarkpharma.com.br
See more website traffic and engagement information

Glenmark Pharmaceuticals Limited Revenue up to November 2025 is > 1B

revenue generated by Glenmark Pharmaceuticals Limited top domains

Glenmark Pharmaceuticals Limited top domains revenue over 3 years

Revenue for Glenmark Pharmaceuticals Limited top domains

glenmarkpharma.comglenmarkpharma.com> 1B
glenmarkpharma-us.comglenmarkpharma-us.com> 1B
glenmarkpharma.com.brglenmarkpharma.com.br> 1B
See more with Sales Intelligence

Glenmark Pharmaceuticals Limited Stock price in November 2025

Glenmark Pharmaceuticals Limited stock is traded under the ticker #GLENMARK. Below you can review Glenmark Pharmaceuticals Limited stock performance in the past 12 months up to November 2025


Total visits to Glenmark Pharmaceuticals Limited's top domains

Understand Glenmark Pharmaceuticals Limited market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown
glenmarkpharma.comglenmarkpharma.com143.3K
glenmarkpharma-us.comglenmarkpharma-us.com10K
glenmarkpharma.com.brglenmarkpharma.com.br2.9K
See more with Sales Intelligence

Avg. visit duration in Glenmark Pharmaceuticals Limited's top domains

Analyze Glenmark Pharmaceuticals Limited engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
glenmarkpharma.comglenmarkpharma.com00:01:49
glenmarkpharma-us.comglenmarkpharma-us.com00:00:35
glenmarkpharma.com.brglenmarkpharma.com.br00:00:53
See more with Sales Intelligence

Avg. pageviews on Glenmark Pharmaceuticals Limited's top domains

See how Glenmark Pharmaceuticals Limited keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
glenmarkpharma.comglenmarkpharma.com2.71
glenmarkpharma-us.comglenmarkpharma-us.com1.43
glenmarkpharma.com.brglenmarkpharma.com.br2.98
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Glenmark Pharmaceuticals Limited

These are the website technologies, by industry, used by Glenmark Pharmaceuticals Limited top domains

Payment & Currencies (23)

PayPal

PayPal

Content Management System (5)

WordPress

WordPress

Advertising (4)

DoubleClick

DoubleClick

Mobile (3)

Meta Viewport

Meta Viewport

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Glenmark Pharmaceuticals Limited

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGlenmark group has issues with recall for multiple lots.Glenmark Pharmaceuticals Inc. has initiated a recall for multiple lots of its bisoprolol fumarate and hydrochlorothiazide tablets, sold under the brand name Ziac, after discovering they may have been cross-contaminated with another drug.
NewsGlenmark group launched Nebzmart GFB Smartules and Glenmark Airz FB Smartules on Nov 25th '25.Mumbai, India, 25 November 2025: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global pharmaceutical company, today announced the launch of Nebzmart(R) GFB Smartules(R) and Glenmark Airz(R) FB Smartules(R), the world's first nebulized, fixed-dose triple therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD).
NewsGlenmark group partnered with Hengrui on Sep 24th '25.Glenmark Pharmaceuticals Ltd on Wednesday announced signing of an exclusive licence and collaboration pact with Hengrui Pharma for development and commercialisation of Trastuzumab Rezetecan that is aimed at treating different types of cancer.

See all Glenmark Pharmaceuticals Limited signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.